Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
06/11/1991 | US5023270 5-Methoxypsoralen administered at bedtime |
06/11/1991 | US5023268 Therapy for cerebral edema |
06/11/1991 | US5023266 Method of treatment of psychotic disorders |
06/11/1991 | US5023263 42-oxorapamycin |
06/11/1991 | US5023262 Hydrogenated rapamycin derivatives |
06/11/1991 | US5023261 Acylated benzofuro[3,2-c]quinoline compounds with utility as treatments for osteoporosis |
06/11/1991 | US5023260 Substituted uracils, processes for their preparation and their use against parasitic protozoa |
06/11/1991 | US5023257 Related to ciprofloxacin, in the form of oily suspension; bacterial infections |
06/11/1991 | US5023256 Pharmacologically active aminoimidazopyridines |
06/11/1991 | US5023255 Triazine derivatives; inhibitors exzyme 5-lipoxygenase |
06/11/1991 | US5023254 Administering antiestrogens |
06/11/1991 | US5023253 Antitumor agents |
06/11/1991 | US5023251 O/W cream containing hydrocortisone diester |
06/11/1991 | US5023249 Fertility drug and method of producing the same |
06/11/1991 | US5023248 Hydroglycemic agents, treatment of hyperketonemia and changes in lipid metabolism |
06/11/1991 | US5023245 Improved niacin formulation |
06/11/1991 | US5023244 Anti-dementia agents |
06/11/1991 | US5023241 Avermectin derivatives |
06/11/1991 | US5023240 Veterinary medicine, humans |
06/11/1991 | US5023238 By amino-tricyano-propene |
06/11/1991 | US5023234 Blocking testicular hormone secretions and administering antiandrogen |
06/11/1991 | US5023184 Antibiotics from myxococcus |
06/11/1991 | US5023090 Topical compositions containing LYCD and other topically active medicinal ingredients for the treatment of ACNE |
06/11/1991 | US5023085 Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals |
06/11/1991 | US5023084 Transdermal estrogen/progestin dosage unit, system and process |
06/11/1991 | US5023079 Heptaene V-28-3 antibiotic derivative |
06/11/1991 | US5023076 Drug delivery |
06/11/1991 | US5023073 Method of combating flupropadine poisoning using phenothiazines |
06/09/1991 | CA2031755A1 Cyclic renin inhibitors |
06/09/1991 | CA2031745A1 Cyclic renin inhibitors containing 2-substituted(3s, 4s)-4-amino-5-cyclohexyl-3-hydroxy pentanoic acid, 2-substituted (3s, 4s)-5-cyclohexyl-3,4-dihydroxy-pentanoic acid or 2 -substituted (4s, 5s)-5-amino-6- yclohexyl-4-hydroxyhexanoic acid or its analogs |
06/09/1991 | CA2031735A1 Cyclic renin inhibitors containing 3(s)-amino-4-cyclohexyl-2(r)-hydroxy-butanoic acid or 4-cyclo-hexyl-(2r, 3s)-dihydroxybutanoic acid or related analogs |
06/09/1991 | CA2031693A1 Antiarrhytmic agents |
06/09/1991 | CA2031685A1 Compounds |
06/09/1991 | CA2031684A1 Pharmaceuticals |
06/09/1991 | CA2031682A1 Hydrogenated nitrogen heterocycles |
06/09/1991 | CA2031680A1 Compounds |
06/09/1991 | CA2031645A1 Class iii antiarrhytmic agents |
06/09/1991 | CA2031633A1 Nitrogen-containing spirocycles |
06/08/1991 | WO1991009027A1 Thiarubrine antifungal and antibiotic agents |
06/08/1991 | WO1991009006A1 New bicyclic amino-substituted compounds |
06/08/1991 | WO1991008668A1 Inhibitors of pneumocystis carinii dihydrofolate reductase |
06/08/1991 | CA2070650A1 Thiarubrine antifungal and antibiotic agents |
06/08/1991 | CA2069941A1 Inhibitors of pneumocystis carinii dihydrofolate reductase |
06/08/1991 | CA2046292A1 Bicyclic amino-substituted compounds |
06/07/1991 | CA2031243A1 Preparation for endermism containing dopamine derivative |
06/06/1991 | DE3939703A1 Verbesserte transdermale applikation von pharmakologisch aktiven verbindungen Improved transdermal application of pharmacologically active compounds |
06/06/1991 | DE3939701A1 Use of avarone and 3'-deoxy-3'-fluoro:thymidine - for synergistic treatment of tumours |
06/06/1991 | DE3939372A1 Mitonafide-infusionsloesung Mitonafide-infusion spoon |
06/06/1991 | CA2031355A1 Non-toxic wound cleansing compositions |
06/06/1991 | CA2031259A1 Heterocyclic compounds |
06/06/1991 | CA2031066A1 Pharmaceutical compositions |
06/05/1991 | WO1991008209A1 Bornyl and isobornyl carboxylic esters of condensed tetrahydroquinoxalines |
06/05/1991 | WO1991008208A1 Heterocyclic substituted naphthyridinones and methods and compositions employing them |
06/05/1991 | WO1991007963A1 Glycyl-p-amino-pyridine for the treatment of senile dementia states |
06/05/1991 | EP0430885A2 Anthelmintical compounds |
06/05/1991 | EP0430883A2 Anthelmintical compounds |
06/05/1991 | EP0430800A1 Substituted benzothiazolinones, process for their preparation and pharmaceutical compositions containing them |
06/05/1991 | EP0430771A1 Isoindolone derivatives, their preparation and their use as intermediates for the preparation of substance P antagonists |
06/05/1991 | EP0430738A2 Use of an imidazopyridine for the manufacture of anesthetic medicaments |
06/05/1991 | EP0430709A2 Benzthiophen derivatives |
06/05/1991 | EP0430693A2 Pyrimidinedione derivative compounds, method for preparing same, and antiarrhythmic agents containing same |
06/05/1991 | EP0430621A2 Process for the preparation of chiral 3,4-epoxy benzopyrans |
06/05/1991 | EP0430556A2 (1-Akylsubstituted) and 1,1-dialkylsubstituted) carbacephalosporins |
06/05/1991 | EP0430552A2 Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds |
06/05/1991 | EP0430551A2 Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds |
06/05/1991 | EP0430539A2 Ocular implants |
06/05/1991 | EP0430518A2 Cyclopentane derivatives |
06/05/1991 | EP0430491A2 Transdermal delivery device for estradiol and process for manufacturing said device |
06/05/1991 | EP0430474A1 Sustained release compositions for treating periodontal disease |
06/05/1991 | EP0430459A1 Tetrahydronaphthalene derivatives and preparation thereof |
06/05/1991 | EP0430414A1 Morphine hydrochloride preparation for rectal administration |
06/05/1991 | EP0430388A2 Use of clomiphene for treatment of infertility |
06/05/1991 | EP0430386A1 14Alpha, 17alpha bridged 16-hydroxyestratrienes |
06/05/1991 | EP0430334A1 Immunostimulating 6-aryl-5,6-dihydroimidazo[2,1-b]thiazole derivatives |
06/05/1991 | EP0430287A2 Sustained-release drug dosage units |
06/05/1991 | EP0430201A2 Aminocarbonylcarbamates related to physostigmine, a process for their preparation and their use as medicaments |
06/05/1991 | EP0430194A2 Aryl-alkyl-azoles substituted with many times unsaturated groups, process for their preparation and their use |
06/05/1991 | EP0430190A2 New tricyclic compounds |
06/05/1991 | EP0430149A2 Pharmaceutical preparations |
06/05/1991 | EP0430114A2 Hexahydro-1H-quino[4,3,2-ef][1,4]benzoxazepines and related compounds, a process and intermediates for their preparation and their use as medicaments |
06/05/1991 | EP0430108A2 Use of oxetanocin-G for the treatment of varicella-zoster virus infections |
06/05/1991 | EP0430078A2 Steroids |
06/05/1991 | EP0430045A2 Ascorbic acid tocopheryl phosphate diesters for inhibition of Maillard's reaction |
06/05/1991 | EP0430036A2 Benzothiazepine metastasis treatment |
06/05/1991 | EP0430035A2 Use of benzothiazepine for the preparation of a medicament for treating seizures |
06/05/1991 | EP0430029A2 Pyridin-2,4- and 2,5-dicarboxylic acid diamides, process for their preparation and their use |
06/05/1991 | EP0430019A2 Transdermal therapeutic system containing buprenorphine as an active component |
06/05/1991 | EP0429999A1 Novel cephalosporins, process for their preparation and their use as medicaments |
06/05/1991 | EP0429987A2 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection |
06/05/1991 | EP0429895A1 Process for preparing monohydrate 7-(D-2-amino-2-phenylacetamido)-3-cefem-4-carboxylic acid and intermediate formed in the process |
06/05/1991 | EP0429868A2 Use of a benzodiazepin- and a phenylpyrrylketone derivative in retroviral infection |
06/05/1991 | EP0429856A2 Pharmaceutical preparation containing a metal salt of ibuprofen and process for making same |
06/05/1991 | EP0429751A2 Substituted 3-amino-sydnonimines, process for their preparation and their use |
06/05/1991 | EP0429732A1 Sustained-release compositions containing cation exchange resins and polycarboxylic polymers |
06/05/1991 | EP0429685A1 Oxoindole derivative |
06/05/1991 | EP0429676A1 Drug for improving brain function |
06/05/1991 | EP0429645A1 Reducing the spread of infection by blood handling equipment |
06/05/1991 | EP0429627A1 Derivatives of quinoline-3-carboxanilide. |
06/05/1991 | EP0429619A1 New process for the preparation of phenyl-guanidine derivatives. |
06/05/1991 | EP0429585A1 Cytochalasin compositions and therapeutic methods |